VDR and heart failure: In addition, paricalcitol, a synthetic analogue of vitamin D3 that selectivelyactivates vitamin D receptors, has been reported to prevent the progression ofventricular dilation and hypertrophy as well as a reduction in ejection fraction,in a murine heart failure model of transverse aortic constriction [34].